The Impact of Body Mass Index on the Endometrial Microbiome in IVF Treatments. Tampere Infertility Microbiome Project (TIMP).
NCT ID: NCT04168567
Last Updated: 2025-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
91 participants
OBSERVATIONAL
2020-08-14
2023-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microbiome and Immunologic Analysis - Women With Endometriosis
NCT04159740
Development of a Microbiome Non-invasive Diagnosis Tool
NCT03330444
New Strategies to Evaluate the Reproductive Tract Microbiome
NCT06920797
Microbiome and Endometrial Receptivity in Obese Infertile Women
NCT03493529
Transcriptomic Evaluation of Endometrial Receptivity
NCT04141085
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese patients
Patients with a BMI higher than 30kg/m² will be included in the first group.
Microbiome analysis
Samples from TIMP microbiome project will be analyzed with NGS techniques.
Normal-weight patients
Patients with a BMI under 25 kg/m² will be included in the second group.
Microbiome analysis
Samples from TIMP microbiome project will be analyzed with NGS techniques.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microbiome analysis
Samples from TIMP microbiome project will be analyzed with NGS techniques.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary or secondary male-type infertility
* BMI over 30 kg/m² or under 25 kg/m²
* Patient's willingness to participate
Exclusion Criteria
* Use of antibiotics during IVF treatment or oocyte retrieval
* Technical diffuculties in embryo transfer or no embryos available for transfer
20 Years
42 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katja Ahinko
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere University Hospital
Tampere, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R18068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.